Delivery Order SPE2DB22D3016-SPE2DB24FBFU3

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $1,857.04 and runs through October 24, 2024. It is a Firm Fixed Price contract, with no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. This contract is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $2,284.22 and an ultimate completion date of February 21, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 100MG TAB 60S, a pharmaceutical product, with a ceiling value of $13,930.20 and a period of performance through July 7, 2025. The contract is a firm fixed-price, non-set-aside award, meaning it was openly competed. AmerisourceBergen Drug Corp is a significant vendor for the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The order is valued at $6,104.90 and has a delivery deadline of October 15, 2024. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The firm-fixed-price contract is valued at $5,612.97 and has a period of performance through September 18, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $5,328.75 and a period of performance ending on May 16, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 100 MG TABLET 60S, with a ceiling value of $2,786.07 and a completion date of July 9, 2025. The contract is a firm fixed-price delivery order, which indicates that specific quantities and prices have been predetermined. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the pharmaceutical product BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $1,188.77 and a completion date of May 13, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leverages its...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a medication, with a ceiling value of $1,857.38 and a period of performance through February 20, 2025. The contract is a firm fixed price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $2,848.01 and a period of performance through May 1, 2025. It is a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBFU3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $1,924.84 and runs through September 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of pharmaceutical and medical supplies, including critical care materials and prescription drugs, to support military treatment programs, veterans' hospitals, and other federal healthcare providers. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for delivering a comprehensive range of medical commodities to various government agencies and facilities.

Generated 12/3/24, 10:05 AM